Generated by Meeveem AI
"Endpoint technology solutions that generate the richest clinical evidence for drug trials"
Clario provides endpoint technology solutions that power clinical trials for pharmaceutical and biotech companies. The company combines scientific expertise with platforms across cardiac safety, eCOA, medical imaging, precision motion, and respiratory endpoints. With over 50 years of experience in more than 100 countries, Clario helps sponsors generate reliable clinical evidence for regulatory approval. The company supports site based, hybrid, and decentralized trial models through validated software, connected devices, and AI solutions. Operating with 24/7 support and multilingual capabilities, Clario simplifies trial execution for sponsors, CROs, and research sites while ensuring patient safety remains central to drug development.
3900
Team Members
1972
Founded
Digital Health
Sector
Hybrid
Work Environment
A world where every clinical trial generates the richest possible evidence, accelerating drug approvals and transforming the lives of patients and their families through better treatments.
Clario transforms lives by unlocking better evidence through scientific expertise, endpoint technologies, and global operational scale.